Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2021 | May 17, 2021 | |
Document Information Line Items | ||
Entity Registrant Name | PACIFIC HEALTH CARE ORGANIZATION INC | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 12,800,000 | |
Amendment Flag | false | |
Entity Central Index Key | 0001138476 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2021 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Interactive Data Current | Yes |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Current Assets | ||
Cash | $ 9,909,751 | $ 9,498,457 |
Accounts receivable, net of allowance of $18,441 and $19,404 | 842,397 | 1,063,090 |
Deferred rent asset | 5,213 | 0 |
Receivable – other | 3,000 | 4,000 |
Prepaid expenses | 73,283 | 82,499 |
Total current assets | 10,833,644 | 10,648,046 |
Property and Equipment, net | ||
Computer equipment | 511,107 | 507,873 |
Furniture and fixtures | 226,323 | 226,323 |
Office equipment | 9,556 | 9,556 |
Total property and equipment | 746,986 | 743,752 |
Less: accumulated depreciation and amortization | (633,324) | (620,705) |
Net property and equipment | 113,662 | 123,047 |
Operating lease right-of-use assets, net | 247,466 | 309,282 |
Other assets | 26,788 | 26,788 |
Total Assets | 11,221,560 | 11,107,163 |
Current Liabilities | ||
Accounts payable | 98,119 | 80,134 |
Accrued expenses | 296,948 | 275,152 |
Income tax payable | 135,837 | 61,828 |
Deferred rent expense | 0 | 2,725 |
Deferred tax liabilities | 19,413 | 19,413 |
Dividend payable | 37,000 | 37,000 |
Operating lease liabilities, current portion | 230,676 | 243,049 |
Paycheck protection program loans, current portion | 0 | 311,118 |
Unearned revenue | 50,107 | 31,544 |
Total current liabilities | 868,100 | 1,061,963 |
Long Term Liabilities | ||
Operating lease liabilities, long term portion | 16,790 | 66,233 |
Paycheck protection program loans, long term portion | 0 | 149,582 |
Total Liabilities | 884,890 | 1,277,778 |
Commitments and Contingencies | 0 | 0 |
Stockholders’ Equity | ||
Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding | 16 | 16 |
Common stock, $0.001 par value, 200,000,000 shares authorized, 12,800,000 shares issued and outstanding | 12,800 | 12,800 |
Additional paid-in capital | 416,057 | 416,057 |
Retained earnings | 9,907,797 | 9,400,512 |
Total stockholders’ equity | 10,336,670 | 9,829,385 |
Total Liabilities and Stockholders’ Equity | $ 11,221,560 | $ 11,107,163 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Accounts receivable, allowance (in Dollars) | $ 18,441 | $ 19,404 |
Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 16,000 | 16,000 |
Preferred stock, shares outstanding | 16,000 | 16,000 |
Common stock par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | 12,800,000 | 12,800,000 |
Common stock, outstanding | 12,800,000 | 12,800,000 |
Series A Preferred Stock [Member] | ||
Preferred stock, shares authorized | 40,000 | 40,000 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Revenues: | ||
Revenues | $ 1,324,362 | $ 1,552,909 |
Expenses: | ||
Depreciation | 12,619 | 17,231 |
Bad debt provision | 0 | 101 |
Consulting fees | 57,123 | 75,693 |
Salaries and wages | 694,618 | 745,989 |
Professional fees | 65,829 | 87,226 |
Insurance | 86,696 | 94,793 |
Outsource service fees | 101,803 | 106,114 |
Data maintenance | 13,296 | 39,728 |
General and administrative | 171,785 | 214,853 |
Total expenses | 1,203,769 | 1,381,728 |
Income from operations | 120,593 | 171,181 |
Paycheck protection program loan forgiveness income | 464,386 | 0 |
Paycheck protection program loan interest expense | (3,686) | 0 |
Total other income (expense) | 460,700 | 0 |
Income before taxes | 581,293 | 171,181 |
Income tax provision | (74,008) | (48,053) |
Net income | $ 507,285 | $ 123,128 |
Earnings per share amount (in Dollars per share) | $ 0.04 | $ 0.01 |
Basic common shares outstanding (in Shares) | 12,800,000 | 12,800,000 |
Fully diluted earnings per share: | ||
Earnings per share amount (in Dollars per share) | $ 0.04 | $ 0.01 |
Fully diluted common shares outstanding (in Shares) | 12,816,000 | 12,816,000 |
HCO [Member] | ||
Revenues: | ||
Revenues | $ 291,254 | $ 326,665 |
MPN [Member] | ||
Revenues: | ||
Revenues | 131,878 | 120,749 |
Utilization review [Member] | ||
Revenues: | ||
Revenues | 265,604 | 296,055 |
Medical bill review [Member] | ||
Revenues: | ||
Revenues | 96,667 | 83,079 |
Medical case management [Member] | ||
Revenues: | ||
Revenues | 484,433 | 677,212 |
Other Revenues [Member] | ||
Revenues: | ||
Revenues | $ 54,526 | $ 49,149 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balances at Dec. 31, 2019 | $ 16 | $ 12,800 | $ 416,057 | $ 8,850,942 | $ 9,279,815 |
Balances (in Shares) at Dec. 31, 2019 | 16,000 | 12,800,000 | |||
Net Income | 123,128 | 123,128 | |||
Balances at Mar. 31, 2020 | $ 16 | $ 12,800 | 416,057 | 8,974,070 | 9,402,943 |
Balances (in Shares) at Mar. 31, 2020 | 16,000 | 12,800,000 | |||
Balances at Dec. 31, 2020 | $ 16 | $ 12,800 | 416,057 | 9,400,512 | 9,829,385 |
Balances (in Shares) at Dec. 31, 2020 | 16,000 | 12,800,000 | |||
Net Income | 507,285 | 507,285 | |||
Balances at Mar. 31, 2021 | $ 16 | $ 12,800 | $ 416,057 | $ 9,907,797 | $ 10,336,670 |
Balances (in Shares) at Mar. 31, 2021 | 16,000 | 12,800,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Cash Flows from Operating Activities: | ||
Net income | $ 507,285 | $ 123,128 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 12,619 | 17,231 |
Bad debt provision | 0 | 101 |
Paycheck protection program loan forgiveness | (460,700) | 0 |
Changes in operating assets and liabilities: | ||
Decrease in accounts receivable | 220,693 | 109,882 |
Decrease in receivable - other | 1,000 | 4,000 |
Decrease (increase) in prepaid expenses | 9,216 | (162) |
Increase in accounts payable | 17,985 | 89,893 |
(Increase) in deferred rent asset | (5,213) | 0 |
(Decrease) in deferred rent expense | (2,725) | (5,673) |
Increase in accrued expenses | 21,796 | 7,645 |
Increase in income tax payable | 74,009 | 48,053 |
Increase in unearned revenue | 18,563 | 10,656 |
Net cash provided by operating activities | 414,528 | 404,754 |
Cash Flows from Investing Activities: | ||
Purchase of furniture and office equipment | (3,234) | (19,637) |
Net cash used in investing activities | (3,234) | (19,637) |
Cash Flows from Financing Activities: | ||
Net cash provided by financing activities | 0 | 0 |
Increase in cash | 411,294 | 385,117 |
Cash at beginning of period | 9,498,457 | 8,104,164 |
Cash at end of period | 9,909,751 | 8,489,281 |
Cash paid for: | ||
Interest | 0 | 0 |
Income taxes paid | $ 0 | $ 0 |
BASIS OF FINANCIAL STATEMENT PR
BASIS OF FINANCIAL STATEMENT PRESENTATION | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] | The accompanying unaudited condensed consolidated financial statements have been prepared by Pacific Health Care Organization, Inc. (the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”). Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations. The information furnished in these interim condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical information and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed consolidated financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2020. Operating results for the three months ended March 31, 2021, are not necessarily indicative of the results to be expected for the year ending December 31, 2021. Principles of Consolidation Basis of Accounting Revenue Recognition The core principle underlying Topic 606 is that the Company will recognize revenue to represent the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The ASU requires the use of a five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues are generated as services are provided to the customer based on the sales price agreed and collected. The Company recognizes revenue as the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred. The Company derives its revenue from the sale of services offered through its HCOs, MPNs, utilization review, medical bill review, medical case management services, lien defense, carve-outs, Medicare set-aside. These services are billed individually as separate components to our customers. These fees include monthly and/or annual HCO and/or MPN administration fees, claim and network access fees, medical bill review fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, utilization review fees, medical case management flat rate fees or hourly fees depending on the agreement with the customer. The Company enters into arrangements for bundled managed care, standalone services, or add-on ancillary services which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as unearned revenue. Accounts Receivables and Bad Debt Allowance The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2021 and December 31, 2020, are as follows: 3/31/2021 12/31/2020 Customer A 19 % 20 % Customer B 16 % 13 % Customer C 5 % 10 % Significant Customers During the periods ended March 31, 2021 and 2020, we had two customers, that accounted for more than 10% of our total sales. The following table sets forth details regarding the percentage of total sales attributable to our significant customers during the three months ended March 31, 2021 and 2020: 3/31/2021 3/31/2020 Customer A 20 % 23 % Customer B 10 % 14 % Leases |
OPERATING LEASES
OPERATING LEASES | 3 Months Ended |
Mar. 31, 2021 | |
Disclosure Text Block [Abstract] | |
Lessee, Operating Leases [Text Block] | NOTE 2 - OPERATING LEASES In July 2015, the Company entered a 79-month lease to lease approximately 9,439 square feet of office space that commenced in September 2015. This office space serves as the Company’s principal executive offices, as well as the principal offices of the Company’s operating subsidiaries. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: Three Months Ended March 31, 2021 Lease Cost Operating lease cost (included in general and administrative in the Company’s condensed consolidated statements of operations) $ 72,946 Other Information Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2021 $ 72,946 Weighted average remaining lease term – operating leases (in years) 1.08 years Average discount rate – operating leases 5.75 % The supplemental balance sheet information related to leases for the period is as follows: At March 31, 2021 At December 31, 2020 Operating leases Long-term right-of-use assets $ 247,466 $ 309,282 Short-term operating lease liabilities $ 230,676 $ 243,049 Long-term operating lease liabilities 16,790 66,233 Total operating lease liabilities $ 247,466 $ 309,282 Maturities of the Company’s lease liabilities are as follows: Year Ending Operating Leases 2021 (remaining 9 months) $ 188,025 2022 71,359 Total lease payments 259,384 Less: Imputed interest/present value discount (11,918 ) Present value of lease liabilities $ 247,466 Lease expenses were $72,946 and $70,582 during the three months ended March 31, 2021 and 2020, respectively. |
PAYCHECK PROTECTION PROGRAM LOA
PAYCHECK PROTECTION PROGRAM LOANS | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | NOTE 3 PAYCHECK PROTECTION PROGRAM LOANS In April and May 2020 Pacific Health Care Organization, Inc. (“PHCO”), Medex Managed Care, Inc. (“MMC”) and Medex Medical Management, Inc. (“MMM”) received loans pursuant to the Coronavirus Aid, Relief and Economic Security (“CARES”) Act Paycheck Protection Program. PHCO received a loan in the amount of $133,400 (the “PHCO PPP Loan”) from Pacific Western Bank which was scheduled to mature on April 21, 2022. The PHCO PPP Loan interest rate was 1% per annum with the full loan amount and interest eligible for forgiveness if forgiveness was applied for within the specified time. MMM and MMC received loans of $267,700 and $59,600 respectively, from First Citizens Bank, (collectively the “Medex Companies PPP Loans”). The Medex Companies PPP Loans were scheduled to mature on April 30, 2022 and May 11, 2022, respectively. The Medex Companies PPP Loans interest rates were 1% per annum with the full loan amount and interest eligible for forgiveness if forgiveness was applied for within the specified time. In February 2021 the principal and interest on the PHCO PPP Loan and the Medex Companies PPP Loans were forgiven in full. The total amount of the loan and interest forgiven for PHCO was $133,400 and $1,067, respectively. The total amount of the principal and interest forgiven for MMM was $267,700 and $2,142, respectively. The total amount of the principal and interest forgiven for MMC was $59,600 and $477, respectively. The funds were used for qualifying expenses as described in the CARES Act, namely payroll, rent, utilities and group health insurance benefits. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | NOTE 4 - SUBSEQUENT EVENTS Economic Aid Act On April 1, 2021, our subsidiary Medex Medical Management, Inc. (“MMM”) received a loan pursuant to section 311 of the Economic Aid Act Paycheck Protection Program Second Draw Loans in the amount of $218,900 (the “Second Draw PPP Loan”). The Second Draw PPP Loan bears an interest rate of 1.0% per annum and is payable monthly commencing on February 28, 2022, if loan forgiveness is not requested by that date. The loan funds are eligible for full forgiveness if used for qualifying expenses, such as payroll, group health benefits, rent and utilities. In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance of this report and, other than the Second Draw PPP Loan, there are no material subsequent events to report. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation |
Basis of Accounting, Policy [Policy Text Block] | Basis of Accounting |
Revenue [Policy Text Block] | Revenue Recognition The core principle underlying Topic 606 is that the Company will recognize revenue to represent the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The ASU requires the use of a five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues are generated as services are provided to the customer based on the sales price agreed and collected. The Company recognizes revenue as the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred. The Company derives its revenue from the sale of services offered through its HCOs, MPNs, utilization review, medical bill review, medical case management services, lien defense, carve-outs, Medicare set-aside. These services are billed individually as separate components to our customers. These fees include monthly and/or annual HCO and/or MPN administration fees, claim and network access fees, medical bill review fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, utilization review fees, medical case management flat rate fees or hourly fees depending on the agreement with the customer. The Company enters into arrangements for bundled managed care, standalone services, or add-on ancillary services which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as unearned revenue. |
Receivable [Policy Text Block] | Accounts Receivables and Bad Debt Allowance The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2021 and December 31, 2020, are as follows: 3/31/2021 12/31/2020 Customer A 19 % 20 % Customer B 16 % 13 % Customer C 5 % 10 % |
Concentration Risk, Customer Risk, Policy [Policy Text Block] | Significant Customers During the periods ended March 31, 2021 and 2020, we had two customers, that accounted for more than 10% of our total sales. The following table sets forth details regarding the percentage of total sales attributable to our significant customers during the three months ended March 31, 2021 and 2020: 3/31/2021 3/31/2020 Customer A 20 % 23 % Customer B 10 % 14 % |
Lessee, Leases [Policy Text Block] | Leases |
BASIS OF FINANCIAL STATEMENT _2
BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Credit Concentration Risk [Member] | |
BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables) [Line Items] | |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2021 and December 31, 2020, are as follows: 3/31/2021 12/31/2020 Customer A 19 % 20 % Customer B 16 % 13 % Customer C 5 % 10 % |
Customer Concentration Risk [Member] | |
BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables) [Line Items] | |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | During the periods ended March 31, 2021 and 2020, we had two customers, that accounted for more than 10% of our total sales. The following table sets forth details regarding the percentage of total sales attributable to our significant customers during the three months ended March 31, 2021 and 2020: 3/31/2021 3/31/2020 Customer A 20 % 23 % Customer B 10 % 14 % |
OPERATING LEASES (Tables)
OPERATING LEASES (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Disclosure Text Block [Abstract] | |
Lease, Cost [Table Text Block] | The components of lease expense and supplemental cash flow information related to leases for the period are as follows: Three Months Ended March 31, 2021 Lease Cost Operating lease cost (included in general and administrative in the Company’s condensed consolidated statements of operations) $ 72,946 Other Information Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2021 $ 72,946 Weighted average remaining lease term – operating leases (in years) 1.08 years Average discount rate – operating leases 5.75 % |
Lessee, Operating Lease, Disclosure [Table Text Block] | The supplemental balance sheet information related to leases for the period is as follows: At March 31, 2021 At December 31, 2020 Operating leases Long-term right-of-use assets $ 247,466 $ 309,282 Short-term operating lease liabilities $ 230,676 $ 243,049 Long-term operating lease liabilities 16,790 66,233 Total operating lease liabilities $ 247,466 $ 309,282 |
Lessee, Operating Lease, Liability, Maturity [Table Text Block] | Maturities of the Company’s lease liabilities are as follows: Year Ending Operating Leases 2021 (remaining 9 months) $ 188,025 2022 71,359 Total lease payments 259,384 Less: Imputed interest/present value discount (11,918 ) Present value of lease liabilities $ 247,466 |
BASIS OF FINANCIAL STATEMENT _3
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) | 3 Months Ended | ||
Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Jan. 01, 2019USD ($) | |
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) [Line Items] | |||
Accounts Receivable, Allowance for Credit Loss | $ 18,441 | $ 19,404 | |
Operating Lease, Right-of-Use Assets | 247,466 | 309,282 | $ 719,861 |
Operating Lease, Liabilities | $ 247,466 | $ 309,282 | $ 719,861 |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | |||
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) [Line Items] | |||
Number of Customers | 2 |
BASIS OF FINANCIAL STATEMENT _4
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - Schedules of Credit Concentration Risk - Credit Concentration Risk [Member] - Accounts Receivable [Member] | 3 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Dec. 31, 2020 | |
Customer A [Member] | ||
Concentration Risk [Line Items] | ||
Credit Concentration Risk, Percentage | 19.00% | 20.00% |
Customer B [Member] | ||
Concentration Risk [Line Items] | ||
Credit Concentration Risk, Percentage | 16.00% | 13.00% |
Customer C [Member] | ||
Concentration Risk [Line Items] | ||
Credit Concentration Risk, Percentage | 5.00% | 10.00% |
BASIS OF FINANCIAL STATEMENT _5
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - Schedules of Customer Concentration Risk - Customer Concentration Risk [Member] - Revenue Benchmark [Member] | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Customer A [Member] | ||
Concentration Risk [Line Items] | ||
Customer Concentration Risk | 20.00% | 23.00% |
Customer B [Member] | ||
Concentration Risk [Line Items] | ||
Customer Concentration Risk | 10.00% | 14.00% |
OPERATING LEASES (Details)
OPERATING LEASES (Details) | 3 Months Ended | ||
Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Jul. 31, 2015ft² | |
Disclosure Text Block [Abstract] | |||
Lessee, Operating Lease, Term of Contract | 79 months | ||
Area of Real Estate Property (in Square Feet) | ft² | 9,439 | ||
Operating Leases, Rent Expense | $ | $ 72,946 | $ 70,582 |
OPERATING LEASES (Details) - Le
OPERATING LEASES (Details) - Lease, Cost | 3 Months Ended |
Mar. 31, 2021USD ($) | |
Lease, Cost [Abstract] | |
Operating lease cost (included in general and administrative in the Company’s condensed consolidated statements of operations) | $ 72,946 |
Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2021 | $ 72,946 |
Weighted average remaining lease term – operating leases (in years) | 1 year 29 days |
Average discount rate – operating leases | 5.75% |
OPERATING LEASES (Details) - _2
OPERATING LEASES (Details) - Lessee, Operating Lease, Disclosure - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 | Jan. 01, 2019 |
Lessee, Operating Lease, Disclosure [Abstract] | |||
Long-term right-of-use assets | $ 247,466 | $ 309,282 | $ 719,861 |
Short-term operating lease liabilities | 230,676 | 243,049 | |
Long-term operating lease liabilities | 16,790 | 66,233 | |
Total operating lease liabilities | $ 247,466 | $ 309,282 | $ 719,861 |
OPERATING LEASES (Details) - _3
OPERATING LEASES (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 | Jan. 01, 2019 |
Lessee, Operating Lease, Liability, Maturity [Abstract] | |||
2021 (remaining 9 months) | $ 188,025 | ||
2022 | 71,359 | ||
Total lease payments | 259,384 | ||
Less: Imputed interest/present value discount | (11,918) | ||
Present value of lease liabilities | $ 247,466 | $ 309,282 | $ 719,861 |
PAYCHECK PROTECTION PROGRAM L_2
PAYCHECK PROTECTION PROGRAM LOANS (Details) - USD ($) | May 11, 2020 | Apr. 30, 2020 | Apr. 21, 2020 | Feb. 28, 2021 |
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Maturity Date | May 11, 2022 | Apr. 30, 2022 | Apr. 21, 2022 | |
Proceeds from Notes Payable | $ 59,600 | $ 267,700 | $ 133,400 | |
Debt Instrument, Interest Rate, Stated Percentage | 1.00% | 1.00% | 1.00% | |
Pacific Health Care Organization, Inc. (“PHCO”) [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | $ 133,400 | |||
Pacific Health Care Organization, Inc. (“PHCO”) [Member] | Interest Expense [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | 1,067 | |||
Medex Managed Care, Inc. (“MMC”) [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | 267,700 | |||
Medex Managed Care, Inc. (“MMC”) [Member] | Interest Expense [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | 2,142 | |||
Medex Medical Management, Inc. (“MMM”) [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | 59,600 | |||
Medex Medical Management, Inc. (“MMM”) [Member] | Interest Expense [Member] | ||||
PAYCHECK PROTECTION PROGRAM LOANS (Details) [Line Items] | ||||
Debt Instrument, Decrease, Forgiveness | $ 477 |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - Subsequent Event [Member] | Apr. 01, 2021USD ($) |
SUBSEQUENT EVENTS (Details) [Line Items] | |
Debt Instrument, Face Amount | $ 218,900 |
Debt Instrument, Interest Rate, Stated Percentage | 1.00% |